Scorpius Holdings Reports Material Agreement and Equity Sales
Ticker: SCPX · Form: 8-K · Filed: May 20, 2025 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | May 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
TL;DR
Scorpius Holdings inked a deal, took on debt, and sold stock on May 15th.
AI Summary
On May 15, 2025, Scorpius Holdings, Inc. entered into a material definitive agreement and incurred a direct financial obligation. The company also reported unregistered sales of equity securities. The filing details these events and includes financial statements and exhibits.
Why It Matters
This filing indicates significant corporate actions, including new financial obligations and equity transactions, which could impact the company's financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements, financial obligations, and unregistered equity sales, which can introduce financial and operational risks.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- NightHawk Biosciences, Inc. (company) — Former company name
- HEAT BIOLOGICS, INC. (company) — Former company name
FAQ
What type of material definitive agreement did Scorpius Holdings, Inc. enter into?
The filing indicates the entry into a material definitive agreement but does not specify the exact nature of the agreement in the provided text.
What is the nature of the direct financial obligation incurred by Scorpius Holdings, Inc.?
The filing states that a direct financial obligation was created, but the specific details of this obligation are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 15, 2025.
What were Scorpius Holdings, Inc.'s former company names?
Scorpius Holdings, Inc. was formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.
What are the key items reported in this 8-K filing?
The key items reported are: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, and Financial Statements and Exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Scorpius Holdings, Inc. (SCPX).